Perspective Therapeutics (CATX) has been on a downward spiral lately with significant selling pressure. After declining 16.6% over the past four weeks, the stock looks well positioned for a trend ...

In this article, we are going to take a look at where Perspective Therapeutics, Inc. (NYSE:CATX) stands against other best multibagger stocks. November has been an eventful month so far for the ...

Truist Financial analyst Nicole Germino maintained a Buy rating on Perspective Therapeutics (CATX – Research Report) yesterday and set a price target of $10.00. The company’s shares closed ...

Bank of America Securities analyst Alec Stranahan reiterated a Hold rating on Perspective Therapeutics (CATX – Research Report) today and set a price target of $6.00. The company’s shares ...

Perspective Therapeutics (NYSE:CATX – Free Report) had its price target cut by Royal Bank of Canada from $16.00 to $15.00 in a research note released on Thursday morning,Benzinga reports.

CATX stock opened at $2.36 on Wednesday. Perspective Therapeutics has a 1-year low of $2.32 and a 1-year high of $19.05. The business’s 50 day moving average is $3.07 and its 200-day moving ...